Monday, October 21, 2002

Study positive for ADHD drug


Shire finds most children do better using extended-release Adderall

By Tim Bonfield
The Cincinnati Enquirer

Children with attention deficit-hyperactivity disorder showed fewer symptoms after switching to a once-a-day medication made by Shire Pharmaceuticals Group, according to a recent clinical trial.

The study looked at nearly 3,000 children with ADHD. Results were presented Oct. 17 in Miami, Fla. at the annual Children and Adults with Attention-Deficit Hyperactivity Disorder International Conference.

The study found that children who switched to Adderall XR, an extended release version of Shire's Adderall medication, had improved social relationships, scholastic, emotional and physical functioning.

ADHD is the most commonly diagnosed psychiatric disorder among school-aged children. Children with ADHD often are inattentive, impulsive, and hyperactive at levels serious enough to interfere with their academic and social functions.

Doctors involved in the study reported that 60 percent of children were much improved or very much improved after using Adderall XR for six weeks compared to their previous treatment.

Family surveys reported that 60 percent of children using regular Adderall showed improved symptoms. Meanwhile, 86 percent of those who switched from Ritalin and 88 percent of those who switched from Concerta reported improvements.

Shire's U.S. corporate headquarters is in Florence, Ky., where it employs about 150 people. Adderall XR is made in New Jersey.

"This large-scale study is important because it demonstrates Adderall XR can be administered safely and is effective in the real-world setting," said the study's lead investigator, Dr. Paul Ambrosini, a professor of psychiatry at MCP Hahnemann University in Philadelphia.

Few children suffered side effects. The most frequently reported adverse events were headache, insomnia, decreased appetite and abdominal pain.

The U.S. Food and Drug Administration approved Adderall XR in October 2001. It is the long-acting version of Adderall.

E-mail tbonfield@enquirer.com



Top headlines
$10K-plus tuition worth it, private-school parents say
The billionaires behind the push for Issue 1
Sex sting arrestee hangs self in jail cell
You're a winner: Family's off to Series
Columns
BRONSON: Conservatives rare species on campus
Cincinnati-Hamilton County
Local Digest
Zoo event scares up fun times for guests
Survivor meeting cancer fight head-on
Study positive for ADHD drug
Checks: River quality improved
Obituary: William Anzer, sports reporter
Election 2002
Democrats try to put squeeze on incumbents
Campaign Notebook: Baby Democrat hears from Chabot
Capitol Notebook: Hagan's extended family didn't inhale
Three Questions with John Green, political analyst
Campaign Cash Update
Candidates on the Web
Butler County
Woman attacked in parking lot
Ohio
OU may privatize on-campus clinic
Ohio asked for more teacher oversight
State historical society won't disturb remains
Ohio Penitentiary's last warden dies
Owner respects ancient mound
Missing Dayton basketball player found in Texas
Kentucky
Man shoots, kills self after car accident
Girl Scout troop hosts chance to meet Kenton Co. candidates
Ky. church: Some truth to sex abuse allegations
Report backs college changes